This site is intended for healthcare professionals only
LoginRegister
Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion dealHyderabad to get Eli Lilly global capability centre
USFDA nod to JnJ Tremfya for Crohns diseaseJnJ Nipocalimab gets USFDA Priority Review designation for generalized myasthenia gravis
Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilitiesNovo Nordisk, Valo Health expand collaboration to discover, develop novel treatments for...
acquisitionBayer arm Vividion Therapeutics acquires Tavros Therapeutics
Dadachanji Group Enters Medical Devices Space, Launches KAIRISH InnotechCDSCO Releases Draft: 1,178 Medical Devices to be Reclassified into 4 Categories, AiMeD Welcomes...
Medicines worth Rs 6,975 crore in MRP terms sold through JAKs in last 10 yearsIndian Pharma industry aims to grow to USD 120-130 billion by 2030: Torrent Group chairman Samir...
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchShilpa Medicare receives European marketing authorization for Tadalafil Orodispersible Films for...
Bayer seeks USFDA nod for FinerenoneBayer seeks USFDA nod for Finerenone for adult patients with heart failure
GSK Shingrix new prefilled syringeGSK Shingrix new prefilled syringe presentation accepted for review by USFDA
Forensic doctors sharing medico legal findings with media before probe may face court action: SCDrug Inspectors Cannot Impose Bans On Drugs: SC
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus DealCDSCO Panel Approves Eli Lilly's Protocol Amendment proposal to study Anti-cancer Drug LY3537982
Torrent Pharma Gets Zero USFDA Observations for Dahej PlantLupin Cystic fibrosis drug gets tentative approval from USFDA
X